Previous 10 | Next 10 |
Penumbra (NYSE:PEN) said its Indigo Aspiration System with Lightning 7 and Lightning 12 secured CE Mark (Conformité Européenne) and are now commercially available in Europe. The company said both technologies are part of its Indigo Aspiration System – now with Intelligen...
Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session blood clot removal in peripheral arterial and venous systems, including the ...
AngioDynamics came in a little short on revenue and supply chain costs are still a significant headwind, but the company's growth-oriented businesses seem to be outperforming. Auryon and AngioVac/AlphaVac are increasingly important to the long-term story, with both performing well in ...
Watching shares of the companies you own drop considerably over a short period can be gut-wrenching. With equity markets so volatile lately, investors may want to look toward healthcare stocks that have been proven winners to anchor their portfolios. Investing in solid companies does no...
Penumbra, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 3, 2022 PR Newswire ALAMEDA, Calif. , April 5, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financia...
Latest offering of REAL Immersive System joins the REAL i-Series as part of a comprehensive virtual reality-based healthcare platform aimed to address a wide range of conditions for more than 50 million patients in the U.S. Expanded content library features activities that can be ...
Penumbra, Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference PR Newswire ALAMEDA, Calif. , March 28, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 21 st An...
Many years ago, it was decided that the definition of a "small cap" should be a company with a valuation under $2 billion. These days, with some mega caps having risen past the $2 trillion mark, we probably should move that benchmark a little. In this roundtable, three Fool contributors wer...
Penumbra’s novel products and international-facing strategy put it on track to absorb the surging demand for minimally invasive vascular procedures. In 2021, Penumbra reported 33% year-over-year revenue gains, with international revenues from cardio and neuro products increasin...
Penumbra has been posting strong revenue growth numbers, but the Street has not been rewarding the shares. The company still has not recovered the share it lost in stroke due to a product recall, but growth is accelerating and the Thunderbolt launch could drive a bigger shift. The...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...